This is especially important in the context of prostate diseases, mainly prostate cancer, in which AR is an important therapeutic target because the expression of genes related to tumor cell proliferation and cell proliferation in BPH are controlled through this receptor. Here, AR is linked to benign prostatic hyperplasia.